Cargando…
MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer
Prior research has shown that critical differences between non-metastatic and metastatic tumor cells are at the level of microRNA. Consequently, harnessing these molecules for the treatment of metastatic cancer could have significant clinical impact. In the present study, we set out to identify meta...
Autores principales: | Yoo, Byunghee, Meka, Nikhil, Sheedy, Patrick, Billig, Ann-Marie, Pantazopoulos, Pamela, Medarova, Zdravka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910689/ https://www.ncbi.nlm.nih.gov/pubmed/31834924 http://dx.doi.org/10.1371/journal.pone.0226356 |
Ejemplares similares
-
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
por: Yoo, Byunghee, et al.
Publicado: (2019) -
Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells
por: Medarova, Zdravka, et al.
Publicado: (2020) -
Guidelines for Rational Cancer Therapeutics
por: Yoo, Byunghee, et al.
Publicado: (2017) -
MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2021) -
Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer
por: Le Fur, Mariane, et al.
Publicado: (2021)